3D Molecular Modelling Study of the H7N9 RNA-Dependent RNA Polymerase as an Emerging Pharmacological Target.
暂无分享,去创建一个
[1] T. Chai,et al. Seroprevalence of avian influenza H9N2 among poultry workers in Shandong Province, China , 2013, European Journal of Clinical Microbiology & Infectious Diseases.
[2] P. Lemey,et al. Genesis of avian-origin H7N9 influenza A viruses , 2013, The Lancet.
[3] Ying Wu,et al. Environmental connections of novel avian-origin H7N9 influenza virus infection and virus adaptation to the human , 2013, Science China Life Sciences.
[4] Wenjun Song,et al. Human infections with the emerging avian influenza A H7N9 virus from wet market poultry: clinical analysis and characterisation of viral genome , 2013, The Lancet.
[5] J. Parry. H7N9 virus is more transmissible and harder to detect than H5N1, say experts , 2013, British medical journal.
[6] Hualan Chen,et al. Isolation and characterization of H7N9 viruses from live poultry markets — Implication of the source of current H7N9 infection in humans , 2013 .
[7] G. Neumann,et al. Genetic analysis of novel avian A(H7N9) influenza viruses isolated from patients in China, February to April 2013. , 2013, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.
[8] J. Parry. H7N9 avian flu infects humans for the first time , 2013, BMJ : British Medical Journal.
[9] E. Holmes,et al. Presence of oseltamivir-resistant pandemic A/H1N1 minor variants before drug therapy with subsequent selection and transmission. , 2012, The Journal of infectious diseases.
[10] I. Barr,et al. Influenza Virus A (H10N7) in Chickens and Poultry Abattoir Workers, Australia , 2012, Emerging infectious diseases.
[11] Y. Lyoo,et al. Genetic characterization of H7N2 influenza virus isolated from pigs. , 2011, Veterinary microbiology.
[12] M. Elhefnawi,et al. Identification of novel conserved functional motifs across most Influenza A viral strains , 2011, Virology Journal.
[13] James M Aramini,et al. Structures of influenza A proteins and insights into antiviral drug targets , 2010, Nature Structural &Molecular Biology.
[14] E. Obayashi,et al. Structural insight into the essential PB1–PB2 subunit contact of the influenza virus RNA polymerase , 2009, The EMBO journal.
[15] Zihe Rao,et al. Crystal structure of an avian influenza polymerase PAN reveals an endonuclease active site , 2009, Nature.
[16] H. Tsuge,et al. Structural Basis of the Influenza A Virus RNA Polymerase PB2 RNA-binding Domain Containing the Pathogenicity-determinant Lysine 627 Residue* , 2009, Journal of Biological Chemistry.
[17] Dimitrios Vlachakis,et al. Gromita: A Fully Integrated Graphical User Interface to Gromacs 4 , 2009, Bioinformatics and biology insights.
[18] Shinji Watanabe,et al. Compatibility among Polymerase Subunit Proteins Is a Restricting Factor in Reassortment between Equine H7N7 and Human H3N2 Influenza Viruses , 2008, Journal of Virology.
[19] E. Obayashi,et al. The structural basis for an essential subunit interaction in influenza virus RNA polymerase , 2008, Nature.
[20] S. Cusack,et al. Host Determinant Residue Lysine 627 Lies on the Surface of a Discrete, Folded Domain of Influenza Virus Polymerase PB2 Subunit , 2008, PLoS pathogens.
[21] Carsten Kutzner,et al. GROMACS 4: Algorithms for Highly Efficient, Load-Balanced, and Scalable Molecular Simulation. , 2008, Journal of chemical theory and computation.
[22] Helena J. Maier,et al. Differential role of the influenza A virus polymerase PA subunit for vRNA and cRNA promoter binding. , 2008, Virology.
[23] Mark von Itzstein,et al. The war against influenza: discovery and development of sialidase inhibitors , 2007, Nature Reviews Drug Discovery.
[24] Tin Wee Tan,et al. Evolutionarily Conserved Protein Sequences of Influenza A Viruses, Avian and Human, as Vaccine Targets , 2007, PloS one.
[25] Yi Guan,et al. Avian Influenza Virus (H5N1): a Threat to Human Health , 2007, Clinical Microbiology Reviews.
[26] David J. Stevens,et al. The structure of H5N1 avian influenza neuraminidase suggests new opportunities for drug design , 2006, Nature.
[27] J. Nguyen-Van-Tam,et al. Outbreak of low pathogenicity H7N3 avian influenza in UK, including associated case of human conjunctivitis. , 2006, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.
[28] Yi Guan,et al. Oseltamivir resistance during treatment of influenza A (H5N1) infection. , 2005, The New England journal of medicine.
[29] Jeffery K. Taubenberger,et al. Characterization of the 1918 influenza virus polymerase genes , 2005, Nature.
[30] M. Marra,et al. Novel Avian Influenza H7N3 Strain Outbreak, British Columbia , 2004, Emerging infectious diseases.
[31] Li Li,et al. RDOCK: Refinement of rigid‐body protein docking predictions , 2003, Proteins.
[32] Wei Zhang,et al. A point‐charge force field for molecular mechanics simulations of proteins based on condensed‐phase quantum mechanical calculations , 2003, J. Comput. Chem..
[33] Bostjan Kobe,et al. Structural Basis for the Specificity of Bipartite Nuclear Localization Sequence Binding by Importin-α* , 2003, Journal of Biological Chemistry.
[34] A. Gingras,et al. Cocrystal Structure of the Messenger RNA 5' Cap-binding Protein (eIF4E) bound to 7-methylGpppG , 2002 .
[35] Thomas L. Madden,et al. Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. , 1997, Nucleic acids research.
[36] B. Rost,et al. Protein fold recognition by prediction-based threading. , 1997, Journal of molecular biology.
[37] A. Gingras,et al. Cocrystal Structure of the Messenger RNA 5′ Cap-Binding Protein (eIF4E) Bound to 7-methyl-GDP , 1997, Cell.
[38] A. Ishihama,et al. The molecular anatomy of influenza virus RNA polymerase. , 1997, Biological chemistry.
[39] J. Thornton,et al. AQUA and PROCHECK-NMR: Programs for checking the quality of protein structures solved by NMR , 1996, Journal of biomolecular NMR.
[40] S. de la Luna,et al. The amino-terminal one-third of the influenza virus PA protein is responsible for the induction of proteolysis , 1996, Journal of virology.
[41] M. Karplus,et al. Evaluation of comparative protein modeling by MODELLER , 1995, Proteins.
[42] D. Hazuda,et al. Inhibition of cap (m7GpppXm)-dependent endonuclease of influenza virus by 4-substituted 2,4-dioxobutanoic acid compounds , 1994, Antimicrobial Agents and Chemotherapy.
[43] J. Thompson,et al. CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. , 1994, Nucleic acids research.
[44] T. Steitz,et al. Structural basis for the 3′‐5′ exonuclease activity of Escherichia coli DNA polymerase I: a two metal ion mechanism. , 1991, The EMBO journal.
[45] R. Krug,et al. Influenza virus gene expression: control mechanisms at early and late times of infection and nuclear-cytoplasmic transport of virus-specific RNAs , 1987, Journal of virology.
[46] E. Kuechler,et al. Identification of the cap binding protein of influenza virus. , 1982, Nucleic acids research.
[47] Katherine Spindler,et al. Rapid evolution of RNA genomes. , 1982, Science.
[48] T. Kuiken,et al. Avian influenza A virus (H7N7) associated with human conjunctivitis and a fatal case of acute respiratory distress syndrome , 2004 .
[49] D. Eisenberg,et al. VERIFY3D: assessment of protein models with three-dimensional profiles. , 1997, Methods in enzymology.
[50] Sean R. Eddy,et al. Multiple Alignment Using Hidden Markov Models , 1995, ISMB.
[51] S. Colowick,et al. Methods in Enzymology , Vol , 1966 .